OTCMKTS:TOMDF Todos Medical (TOMDF) Stock Price, News & Analysis → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free TOMDF Stock Alerts 0.0001 +0.00 (+∞) (As of 04/29/2024) Add Compare Share Share Today's Range0.00▼0.0050-Day Range N/A52-Week Range0.00▼0.00Volume48,100 shsAverage Volume15.30 million shsMarket Capitalization$213,042.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Todos Medical alerts: Email Address Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. About Todos Medical Stock (OTCMKTS:TOMDF)Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.Read More TOMDF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TOMDF Stock News HeadlinesApril 5, 2024 | morningstar.comTodos Medical Ltd TOMDFDecember 23, 2023 | finanznachrichten.deTodos Medical Ltd.: Todos Medical Announces Insolvency Proceedings in IsraelDecember 22, 2023 | finance.yahoo.comTodos Medical Announces Insolvency Proceedings in IsraelOctober 2, 2023 | investing.comTOMDF Historical DataSeptember 26, 2023 | finance.yahoo.comTodos Medical Provides Corporate Update: Retooling to Focus on Long COVID EpidemicAugust 30, 2023 | finance.yahoo.comTodos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ IngredientsMay 24, 2023 | finance.yahoo.comTodos Medical Ltd. (TOMDF)March 31, 2023 | finance.yahoo.comTodos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testingMarch 28, 2023 | proactiveinvestors.comTodos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic testMarch 28, 2023 | finance.yahoo.comTodos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen DiagnosticsMarch 27, 2023 | finance.yahoo.comTodos Medical Begins Trading on the OTC Pink MarketplaceMarch 17, 2023 | proactiveinvestors.comTodos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patientsMarch 15, 2023 | finance.yahoo.comTodos Medical Supports Long COVID Awareness DayMarch 13, 2023 | finance.yahoo.comTodos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note HoldersFebruary 24, 2023 | proactiveinvestors.comTodos Medical releases corporate update around validation plan for PCR-based Avian Influenza testingFebruary 23, 2023 | proactiveinvestors.comTodos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rolloutFebruary 14, 2023 | proactiveinvestors.comTodos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humansFebruary 14, 2023 | finance.yahoo.comTodos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista DiagnosticsJanuary 21, 2023 | seekingalpha.comTOMDF Todos Medical Ltd.December 6, 2022 | finance.yahoo.comTodos Medical to Present at the RHK 2022 Disruptive Growth ConferenceNovember 29, 2022 | finance.yahoo.comTodos Medical’s 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022November 22, 2022 | finance.yahoo.comTodos Medical to Attend World Antiviral CongressNovember 16, 2022 | proactiveinvestors.comTodos Medical signs agreement to sell supplements via Affy Services’ Smart Automated Retail NetworkNovember 16, 2022 | finance.yahoo.comTodos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail NetworkNovember 15, 2022 | proactiveinvestors.comTodos Medical on track with Videssa commercialization following eventful third quarterSee More Headlines Receive TOMDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Todos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:TOMDF CUSIPN/A CIK1645260 Webtodosmedical.com Phone972732077259FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$12.23 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,130,420,000Free FloatN/AMarket Cap$213,042.00 OptionableNot Optionable Beta0.05 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Gerald E. Commissiong (Age 41)CEO, President & Director Comp: $465.27kMr. Daniel Hirsch (Age 55)CFO & Director Comp: $315.27kMr. Chris GrossVice President of OperationsDr. Jorge A. Leon Ph.D.Chief Science OfficerDr. Paula T. Trzepacz M.D.Chief Medical Officer of NeurologyDr. Joseph WeeManaging Director of SingaporeMs. Ilanit Halperin CPA (Age 53)Corporate Controller More ExecutivesKey CompetitorsMotus GINASDAQ:MOTSH-CYTEOTCMKTS:HCYTDProSomnusNASDAQ:OSAPQuantRx BiomedicalOTCMKTS:QTXBPresbiaOTCMKTS:LENSFView All Competitors TOMDF Stock Analysis - Frequently Asked Questions How have TOMDF shares performed in 2024? Todos Medical's stock was trading at 0.00 at the beginning of the year. Since then, TOMDF stock has decreased by 50.0% and is now trading at 0.00. View the best growth stocks for 2024 here. How do I buy shares of Todos Medical? Shares of TOMDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TOMDF) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Todos Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Todos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.